共查询到20条相似文献,搜索用时 595 毫秒
1.
Chen XP Qian LL Jiang H Chen JH 《International journal of clinical oncology / Japan Society of Clinical Oncology》2011,16(5):519-523
Background
Ginsenoside Rg3 is an extract from the natural product ginseng. Previous studies have linked Rg3 with anti-metastasis of cancer in vivo and in vitro. CXC receptor 4 (CXCR4) is a vital molecule in migration and homing of cancer to the docking regions. 相似文献2.
Fernando SF Guimarães Lucas F Andrade Sharon T Martins Ana PR Abud Reginaldo V Sene Carla Wanderer Inés Tiscornia Mariela Bollati-Fogolín Dorly F Buchi Edvaldo S Trindade 《BMC cancer》2010,10(1):113
Background
Melanoma is the most aggressive form of skin cancer and the most rapidly expanding cancer in terms of worldwide incidence. Chemotherapeutic approaches to treat melanoma have had only marginal success. Previous studies in mice demonstrated that a high diluted complex derived from Calcarea carbonica (M8) stimulated the tumoricidal response of activated lymphocytes against B16F10 melanoma cells in vitro. 相似文献3.
4.
Background
Progress in lung cancer is hampered by the lack of clinically useful diagnostic markers. The goal of this study was to provide a detailed evaluation of lung cancer tumor markers indicative of molecular abnormalities and to assess their diagnostic utility in non-small cell lung cancer (NSCLC) patients. 相似文献5.
Bárbara Peleteiro Nuno Lunet Rita Barros Carlo La Vecchia Henrique Barros 《Cancer causes & control : CCC》2010,21(8):1257-1264
Objective
This study aimed to identify sources of underestimation of the association between Helicobacter pylori infection and non-cardia gastric cancer, in a high-risk European population. 相似文献6.
Outi Kilpivaara Matias Rantanen Anitta Tamminen Kristiina Aittomäki Carl Blomqvist Heli Nevanlinna 《BMC cancer》2008,8(1):71
Background
A recent genome wide case-control association study identified NuMA region on 11q13 as a candidate locus for breast cancer susceptibility. Specifically, the variant Ala794Gly was suggested to be associated with increased risk of breast cancer. 相似文献7.
Jürgen Veeck Erik Noetzel Nuran Bektas Edgar Jost Arndt Hartmann Ruth Knüchel Edgar Dahl 《Molecular cancer》2008,7(1):83
Background
We have previously reported that expression of the Wnt antagonist genes SFRP1 and SFRP5 is frequently silenced by promoter hypermethylation in breast cancer. SFRP2 is a further Wnt inhibitor whose expression was recently found being downregulated in various malignancies. Here we investigated whether SFRP2 is also implicated in human breast cancer, and if so whether SFRP2 promoter methylation might serve as a potential tumor biomarker. 相似文献8.
Yoram Barak Frank Schreiber Steve H Thorne Christopher H Contag Dirk deBeer A Matin 《BMC cancer》2010,10(1):146
Background
Bacterial targeting of tumours is an important anti-cancer strategy. We previously showed that strain SL7838 of Salmonella typhimurium targets and kills cancer cells. Whether NO generation by the bacteria has a role in SL7838 lethality to cancer cells is explored. This bacterium has the mechanism for generating NO, but also for decomposing it. 相似文献9.
Background
Lung cancer is relatively resistant to radiation treatment and radiation pneumonitis is a major obstacle to increasing the radiation dose. We previously showed that Caffeic acid phenethyl ester (CAPE) induces apoptosis and increases radiosensitivity in lung cancer. To determine whether CAPE, an antioxidant and an inhibitor of NF-kappa B, could be a useful adjuvant agent for lung cancer treatment, we examine the effects of CAPE on irradiated normal lung tissue in this study. 相似文献10.
McKeage MJ Fong PC Hong X Flarakos J Mangold J Du Y Tanaka C Schran H 《Cancer chemotherapy and pharmacology》2012,69(5):1145-1154
Purpose
To determine the mass balance, excretion and metabolism of the small molecule flavonoid tumour vascular disrupting agent ASA404 in patients with advanced cancer. 相似文献11.
12.
Malene Herbsleb Ole F Christensen Thomas Thykjaer Carsten Wiuf Michael Borre Torben F Ørntoft Lars Dyrskjøt 《BMC cancer》2008,8(1):37
Background
Carcinoma in situ (CIS) is believed to be a precursor of invasive bladder cancer. Identification of CIS is a valuable prognostic factor since radical treatment strategies can be offered these patients before the disease becomes invasive. 相似文献13.
Background
Triphala is commonly used in Ayurvedic medicine to treat variety of diseases; however its mechanism of action remains unexplored. This study elucidates the molecular mechanism of Triphala against human pancreatic cancer in the cellular and in vivo model. 相似文献14.
Takakuwa O Oguri T Ozasa H Uemura T Kasai D Miyazaki M Maeno K Sato S 《Cancer chemotherapy and pharmacology》2011,68(3):669-676
Purpose
Amrubicin, a totally synthetic 9-aminoanthracycline anticancer drug, has shown promising activity for lung cancer, but little is known about the mechanism of resistance for this agent. This study was aimed to clarify the role of P-glycoprotein (P-gp) in amrubicinol, an active metabolite of amrubicin, resistance in lung cancer cells. 相似文献15.
Scarlett Reincke Lina Govbakh Bettina Wilhelm Haiyan Jin Natalia Bogdanova Michael Bremer Johann H Karstens Thilo Dörk 《BMC cancer》2008,8(1):52
Background
MDM4 is a negative regulator of p53 and cooperates with MDM2 in the cellular response to DNA damage. It is unknown, however, whether MDM4 gene alterations play some role in the inherited component of breast cancer susceptibility. 相似文献16.
Parmar S Stingl JC Huber-Wechselberger A Kainz A Renner W Langsenlehner U Krippl P Brockmöller J Haschke-Becher E 《Breast cancer research : BCR》2011,13(3):R57
Introduction
Epirubicin is a common adjuvant treatment for breast cancer. It is mainly eliminated after glucuronidation through uridine diphosphate-glucuronosyltransferase 2B7 (UGT2B7). The present study aimed to describe the impact of the UGT2B7 His268Tyr polymorphism on invasive disease-free survival in breast cancer patients after epirubicin treatment. 相似文献17.
Pamela S Larson Benjamin L Schlechter Chia-Lin King Qiong Yang Chelsea N Glass Charline Mack Robert Pistey Antonio de las Morenas Carol L Rosenberg 《BMC cancer》2008,8(1):68
Background
CDKN1C (also known as p57KIP2) is a cyclin-dependent kinase inhibitor previously implicated in several types of human cancer. Its family members (CDKN1A/p21CIP1 and B/p27KIP1) have been implicated in breast cancer, but information about CDKN1C's role is limited. We hypothesized that decreased CDKN1C may be involved in human breast carcinogenesis in vivo. 相似文献18.
Soumya J Koppikar Amit S Choudhari Snehal A Suryavanshi Shweta Kumari Samit Chattopadhyay Ruchika Kaul-Ghanekar 《BMC cancer》2010,10(1):210
Background
Chemoprevention, which includes the use of synthetic or natural agents (alone or in combination) to block the development of cancer in human beings, is an extremely promising strategy for cancer prevention. Cinnamon is one of the most widely used herbal medicines with diverse biological activities including anti-tumor activity. In the present study, we have reported the anti-neoplastic activity of cinnamon in cervical cancer cell line, SiHa. 相似文献19.
Background
Cancer cells recurrently develop into acquired resistance to the administered drugs. The iatrogenic mechanisms of induced chemotherapy-resistance remain elusive and the degree of drug resistance did not exclusively correlate with reductions of drug accumulation, suggesting that drug resistance may involve additional mechanisms. Our aim is to define the potential targets, that makes drug-sensitive MCF-7 breast cancer cells turn to drug-resistant, for the anti-cancer drug development against drug resistant breast cancer cells. 相似文献20.